Corey S. Goodman

CIK: 0001278411

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALXO

ALX ONCOLOGY HOLDINGS INC

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ALXO
ALX ONCOLOGY HOLDINGS INC
Feb 2, 2026
Purchase(P)
Indirect
3.2M shares at avg. $1.57$5.0M
ALXO
ALX ONCOLOGY HOLDINGS INC
Jan 20, 2026
Award(A)
Stock Option (right to buy)
Direct
40.4K shares-
ALXO
ALX ONCOLOGY HOLDINGS INC
Jan 21, 2025
Award(A)
Stock Option (right to buy)
Direct
40.4K shares-

		Type	Shares	Price		Ownership
Feb 2, 2026	ALXO ALX ONCOLOGY HOLDINGS INC	Purchase(P)	3,184,713	$1.57	$4,999,999	Indirect
Jan 20, 2026	ALXO ALX ONCOLOGY HOLDINGS INC	Award(A) Stock Option (right to buy)	40,400	-	-	Direct
Jan 21, 2025	ALXO ALX ONCOLOGY HOLDINGS INC	Award(A) Stock Option (right to buy)	40,400	-	-	Direct

1-3 of 3 transactions

About GOODMAN COREY S

GOODMAN COREY S (SEC CIK 0001278411) files insider reports with the SEC as Director of ALX ONCOLOGY HOLDINGS INC (ALXO).

Signal8 holds 3 ownership filings by GOODMAN COREY S, all Form 4s, filed between Jan 23, 2025 and Feb 4, 2026. Those filings report 3 transactions, from Jan 21, 2025 to Feb 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GOODMAN COREY S's filings is in SAN FRANCISCO, CA.

Recent filings by GOODMAN COREY S

Feb 2, 2026: Open-market purchase of ALXO shares (Form 4, code P).
Jan 20, 2026: Grant or award of ALXO derivative securities (Form 4, code A).
Jan 21, 2025: Grant or award of ALXO derivative securities (Form 4, code A).

Other insiders filing for ALX ONCOLOGY HOLDINGS INC (ALXO)

Lettmann Jason, CHIEF EXECUTIVE OFFICER
Wong Shelly, SVP, FINANCE AND CAO
Knight Jeff E., Chief Dev & Operating Officer
Klencke Barbara, Chief Medical Officer
Shantharam Harish, Chief Financial Officer
Garland J. Scott, Director

How to read Form 4 transaction codes